Indium (111 In)
Indium (111 In) Uses, Dosage, Side Effects, Food Interaction and all others data.
Indium (111 In) is under investigation in clinical trial NCT00493454 (Ibritumomab Tiuxetan for Treatment of Non-Follicular CD20+ Indolent Lymphomas).
| Trade Name | Indium (111 In) |
| Generic | Indium In-111 |
| Indium In-111 Other Names | Indium (111 In) |
| Type | |
| Formula | In |
| Weight | Average: 110.9051 Monoisotopic: 110.905110677 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Indium (111 In)
